BioSpace News Archive

Pharm Country

iECURE Receives FDA Fast Track Designation for ECUR-506 for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

iECURE, Inc. announced today that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ECUR-506, the company’s in vivo gene insertion program designed to treat neonatal onset Ornithine Transcarbamylase (OTC) deficiency.

May 7, 2024
·
5 min read
Biotech Bay

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

NovaBay® Pharmaceuticals, Inc., a company developing and commercializing high-quality eyecare and wound care products, announces record ordered product sales during the month of April for its Avenova-branded eyecare products on Amazon.com, the Company’s largest sales channel.

May 7, 2024
·
4 min read
BioMidwest

ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials

ARTBIO, Inc. and Nucleus RadioPharma Inc. announced a strategic manufacturing and supply agreement to support ARTBIO’s therapeutic product manufacturing.

May 7, 2024
·
3 min read
Business

Cellarity Appoints Head of Platform to Advance Vision for Novel Drug Creation

Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced the appointment of Christopher Woelk, Ph.D., as Vice President and Head of Platform.

May 7, 2024
·
3 min read
Business

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Journey Medical Corporation announced the Company will release its first quarter 2024 financial results after the U.S. financial markets close on Monday, May 13, 2024.

May 7, 2024
·
2 min read
Biotech Bay

Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Vistagen today announced that company management will present and host one-on-one meetings during the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14 and 15, 2024 in New York City.

May 7, 2024
·
1 min read
Biotech Beach

Milken Institute Announces Key Initiatives at the 2024 Global Conference to Shape the Future of Health

The Milken Institute announced new initiatives to shape the future of health through partnerships and collaboration at its 2024 Global Conference in Los Angeles.

May 7, 2024
·
7 min read
Business

Nimbus Therapeutics Appoints Anita Scheuber, M.D., Ph.D., as Senior Vice President, Therapeutic Area Head, Oncology

Nimbus Therapeutics today announced the appointment of Anita Scheuber, M.D., Ph.D., as Senior Vice President, Therapeutic Area Head, Oncology.

May 7, 2024
·
3 min read
Biotech Beach

ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®

ImmunityBio, Inc. announced that the drug substance has been completed and successfully qualified for “fill finish”, sufficient for 170,000 doses of 400mcg ANKTIVA.

May 7, 2024
·
8 min read
Pharm Country

UroGen Pharma to Participate at Upcoming May 2024 Investor Conferences

UroGen Pharma Ltd., a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, announced that it will present at the following investor conferences in May.

May 7, 2024
·
1 min read